Incretins and SGLT-2i Therapy of Type 2 Diabetes - Real Life Study of Their Therapeutic and Economic Effects

• Main Authors: Zornitsa Mitkova (Author), Konstantin Mitov (Author), Vasil Valov (Author), Manoela Manova (Author), Alexandra Savova (Author), Maria Kamusheva (Author), Dimitar Tcharaktchiev (Author), Zhivko Angelov (Author), Galia Angelova (Author), Guenka Petrova (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

AimIncretins [dipeptidyl peptidase-4 inhibitors (DPP-4i) and glucagon-like peptide 1 RA (GLP-1 RA)] and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) groups are now routinely used for type 2 diabetes therapy and comprise a large number of medicinal products. The long term therapeutic and econo...